Efficacy of human recombinant interleukin 10 (IL-10) prior to re-treatment with interferon α-2b and ribavirin in chronic hepatitis C patients who failed to respond to a previous course of interferon α-2b and ribavirin.

被引：0
|
作者：
Sponseller, CA
Goudey, KL
Brass, CA
Bacon, BR
机构：
[1] St Louis Univ, St Louis, MO 63103 USA
[2] Integrated Therapeut Grp Inc, Kenilworth, NJ USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1625
引用
收藏
页码：578A / 578A
页数：1
相关论文
共 50 条
  • [1] Interleukin-2 plus ribavirin versus interferon-α-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-α-2b treatment
    Malaguarnera, M
    Pistone, G
    Neri, S
    Romano, M
    Brogna, A
    Musumeci, S
    BIODRUGS, 2004, 18 (06) : 407 - 413
  • [2] Interleukin-2 Plus Ribavirin Versus Interferon-α-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-α-2b Treatment
    Mariano Malaguarnera
    Giovanni Pistone
    Sergio Neri
    Marcello Romano
    Alfio Brogna
    Salvatore Musumeci
    BioDrugs, 2004, 18 : 407 - 413
  • [3] Alfa interferon 2b and Ribavirin for treatment of patients with chronic hepatitis C who have failed alpha interferon 2b as single therapy.
    Blanchard, D
    Reed, T
    Freeman, S
    Weiner, K
    Bader, T
    HEPATOLOGY, 1998, 28 (04) : 284A - 284A
  • [4] Interferon-α2b/ribavirin (REBETRON®) treatment for chronic hepatitis C -: Population pharmacokinetics and pharmacodynamics of ribavirin.
    Glue, P
    Jen, F
    Gupta, SK
    Lau, G
    HEPATOLOGY, 1999, 30 (04) : 190A - 190A
  • [5] Efficacy of high dose consensus interferon for the treatment of chronic hepatitis C non responders to interferon alpha 2b and ribavirin.
    Moskovitz, DN
    Manoharan, P
    Heathcote, J
    HEPATOLOGY, 2001, 34 (04) : 577A - 577A
  • [6] Interferon alfacon-1 and ribavirin versus interferon α-2b and ribavirin in the treatment of chronic hepatitis C
    Sjogren, MH
    Sjogren, R
    Holtzmuller, K
    Winston, B
    Butterfield, B
    Drake, S
    Watts, A
    Howard, R
    Smith, M
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (04) : 727 - 732
  • [7] Interferon Alfacon-1 and Ribavirin Versus Interferon α-2b and Ribavirin in the Treatment of Chronic Hepatitis C
    Maria H. Sjogren
    Robert Sjogren
    Kent Holtzmuller
    Bradley Winston
    Betty Butterfield
    Stanley Drake
    Amber Watts
    Robin Howard
    Milton Smith
    Digestive Diseases and Sciences, 2005, 50 : 727 - 732
  • [8] Pegylated interferon α-2b plus ribavirin in the re-treatment of patients non responsive to IFN/ribavirin
    Taliani, G
    Aceti, A
    Capanni, M
    Esperti, E
    Ferrari, C
    Forte, P
    Framarin, L
    Guadagnino, V
    Leoncini, E
    Luchi, S
    Marino, N
    Mazzotta, E
    Milani, S
    Pasquazzi, C
    Rosina, E
    Tacconi, D
    Stroffolini, T
    Zignego, AL
    JOURNAL OF HEPATOLOGY, 2005, 42 : 222 - 222
  • [9] Response to interferon alpha 2B plus ribavirin in hepatitis C infected patients who failed interferon alpha 2B monotherapy.
    King, JW
    Favrot, DR
    Shakhashiro, A
    Gholson, CF
    Balart, LA
    Achord, J
    Kirkikis, JA
    Lyles, WE
    Hollier, JD
    Srinivas, D
    HEPATOLOGY, 1998, 28 (04) : 708A - 708A
  • [10] Virologic response in patients with chronic hepatitis C after treatment with interferon 2b alone or in combination with ribavirin.
    Futuh, ARA
    Solayman, AEM
    El Hendawy, SM
    El Hadad, SM
    Omar, MM
    Kamel, MM
    HEPATOLOGY, 2002, 36 (04) : 589A - 589A
12345